Prognostic significance of E-cadherin expression in hepatocellular carcinoma: A meta-analysis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Chen, Jiang ^a   Zhao, Jie ^a   Ma, Rui ^a   Lin, Hui ^a   Liang, Xiao ^a   Cai, Xiujun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN; CADHERIN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CELL DIFFERENTIATION; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; LIVER CELL CARCINOMA; METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SYSTEMATIC REVIEW (TOPIC); TUMOR INVASION; ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; MALE; META ANALYSIS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84905437896     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103952     Document Type: Article

References (55)

1. Li WQ, Park Y, McGlynn KA, Hollenbeck AR, Taylor PR, et al. (2014) Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study. Hepatology: [Epub ahead of print].
2. Ladep NG, Khan SA, Crossey MM, Thillainayagam AV, Taylor-Robinson SD, et al. (2014) Incidence and mortality of primary liver cancer in England and Wales: Changing patterns and ethnic variations. World Journal of Gastroenterology 20: 1544-53.
3. Yip B, Wantuck JM, Kim LH, Wong RJ, Ahmed A, et al. (2013) Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma. Digestive Diseases and Sciences 59: 192-200.
4. Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, et al. (2013) An Updated Report of the Trends in Cancer Incidence and Mortality in Japan. Japanese Journal of Clinical Oncology 43: 492-507.
5. Gao J, Xie L, Chen WQ, Zhang SW, Wu QJ, et al. (2013) Rural-urban, sex variations, and time trend of primary liver cancer incidence in China, 1988-2005. European Journal of Cancer Prevention 22: 448-54.
6. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA (2014) Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 109: 542-53.
7. Lee SC, Tan HT, Chung MC (2014) Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: Current status and future prospects. World Journal of Gastroenterology 20: 3112-24.
8. Fox R, Berhane S, Teng M, Cox T, Tada T, et al. (2014) Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model. Br J Cancer 110: 2090-8.
9. Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, et al. (2014) Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma. Journal of Cancer 5: 221-30.
10. Lee HJ, Yeon JE, Suh SJ, Lee SJ, Yoon EL, et al. (2014) Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma. Gut and Liver 8: 177-85.
11. Sekar P, Bharti JN, Nigam JS, Sharma A, Soni PB (2014) Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors. Journal of Oncology. [Epub ahead of print].
12. Pectasides E, Rampias T, Sasaki C, Perisanidis C, Kouloulias V, et al. (2014) Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC). PLoS ONE 9: e94273.
13. Pryczynicz A, Guzińska-Ustymowicz K, Niewiarowska K, Cepowicz D, Kemona A (2014) PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer. Tumor Biology. [Epub ahead of print].
14. Chen Z, He X, Jia M, Liu Y, Qu D, et al. (2013) β-catenin Overexpression in the Nucleus Predicts Progress Disease and Unfavourable Survival in Colorectal Cancer: A Meta-Analysis. PLoS ONE 8: e63854.
15. Breier G, Grosser M, Rezaei M (2014) Endothelial cadherins in cancer. Cell and Tissue Research 355: 523-7.
16. Fan CC, Wang TY, Cheng YA, Jiang S, Cheng CW, et al. (2013) Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 139: 1735-44.
17. Jung SP, Kim S, Nam SJ, Kim I, Bae JW (2013) The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis. J Breast Cancer 16: 16-22.
18. Tanaka Y, Terai Y, Kawaguchi H, Fujiwara S, Yoo S, et al. (2013) Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer. Cancer Biol Ther 14: 13-19.
19. Luo SL, Xie YG, Li Z, Ma JH, Xu X (2014) E-cadherin expression and prognosis of oral cancer: a meta-analysis. Tumor Biology. [Epub ahead of print].
20. Xing XB, Tang YB, Yuan G, Wang Y, Wang J, et al. (2013) The prognostic value of E-cadherin in gastric cancer: A meta-analysis. International Journal of Cancer 132: 2589-96.
21. He X, Chen Z, Jia M, Zhao X (2013) Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. PLoS One 8: e70858.
22. Xia L, Huang W, Tian D, Zhu H, Qi X, et al. (2013) Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology 57: 610-24.
23. Zhang L, Huang G, Li X, Zhang Y, Jiang Y, et al. (2013) Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. BMC Cancer 13: 108.
24. Zhan P, Ji YN (2014) Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg Nutr 3: 11-7.
25. Chen J, Sun MX, Hua YQ, Cai ZD (2014) Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 140: 1205-10.
26. Yamaoka K, Nouchi T, Tazawa J, Hiranuma S, Marumo F, et al. (1995) Expression of gap junction protein connexm 32 and E-cadherin in human hepatocellular carcinoma. J Hepatol 22: 536-9.
27. Ihara A, Koizumi H, Hashizume R, Uchikoshi T (1996) Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 23: 1441-7. (Pubitemid 26181227)
28. Matsumura T, Makino R, Mitamura K (2001) Epigenetic Changes in the Malignant Progression of Frequent Down-Regulation of E-cadherin by Genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 7: 594-9. (Pubitemid 32707984)
29. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, et al. (2002) Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features. Hepatology 36: 692-701. (Pubitemid 34977181)
30. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, et al. (2003) Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163: 1371-8. (Pubitemid 37175085)
31. Herath NI, Walsh MD, Kew MC, Young J, Leggett BA, et al. (2004) Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa. J Gastroenterol Hepatol 19: 676-82. (Pubitemid 38858202)
32. Kwon GY, Yoo BC, Koh KC, Cho JW, Park WS, et al. (2005) Promoter Methylation of E-cadherin in Hepatocellular Carcinomas and Dysplastic Nodules. J Korean Med Sci 20: 242-7.
33. Liu J, Lian Z, Han S, Waye MMY, Wang H, et al. (2005) Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 25: 1008-17.
34. Guo C, Liu QG, Yang W, Zhang ZL, Yao YM (2008) Relation among p130Cas, E-cadherin and β-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 7: 490-6.
35. Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, et al. (2008) Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma. Human Pathology 39: 1777-83.
36. Du GS, Wang JM, Lu JX, Li Q, Ma CQ, et al. (2009) Expression of P-aPKC-i, E-Cadherin, and β-Catenin Related to Invasion and Metastasis in Hepatocellular Carcinoma. Annals of Surgical Oncology 16: 1578-86.
37. Woo HY, Min AL, Choi JY, Bae SH, Yoon SK, et al. (2011) Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma. The Korean Journal of Hepatology 17: 12-8.
38. Zhao XL, Sun T, Che N, Sun D, Zhao N, et al. (2011) Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Journal of Cellular and Molecular Medicine 15: 691-700.
39. Xia H, Ooi LLPJ, Hui KM (2012) MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma. PLoS ONE 7: e44206.
40. Ding S, Zhang W, Xu Z, Xing C, Xie H, et al. (2013) Induction of an EMT-like transformation and MET invitro. J Transl Med 11: 164.
41. Hashiguchi M, Ueno S, Sakoda M, Iino S, Hiwatashi K, et al. (2013) Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer 13: 572.
42. Liu TA, Jan YJ, Ko BS, Liang SM, Chen SC, et al. (2013) 14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma. PLoS ONE 8: e57968.
43. Pan JJ, Ge YS, Xu GL, Jia WD, Liu WF, et al. (2013) The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 139: 1043-54.
44. Endo K, Ueda T, Ueyama J, Ohta T, Terada T (2000) Immunoreactive ecadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients. Human Pathology 31: 558-65.
45. Asayama Y, Taguchi Ki K, Aishima Si S, Nishi H, Masuda K, et al. (2002) The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Liver 22: 43-50. (Pubitemid 34552524)
46. Satoshi I, Masayuki I, Shinya A, Toru K, Masao H, et al. (2002) Expression and Prognostic Roles of b-Catenin in Hepatocellular Carcinoma Correlation with Tumor Progression and Postoperative Survival. Clinical Cancer Research 8: 450-6.
47. Yamaoka H, Ohtsu K, Sueda T, Yokoyama T, Hiyama E (2006) Diagnostic and prognostic impact of β-catenin alterations in pediatric liver tumors. Oncol Rep 15: 551-6.
48. Cho SB, Lee KH, Lee JH, Park SY, Lee WS, et al. (2008) Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma. Pathology International 58: 635-42.
49. Wu LQ, Lu Y, Lu HJ, Lv ZH (2008) Can E-cadherin and CD34 be used as indicators of prognosis for hepatocellular carcinoma patients? Clinical Chemistry and Laboratory Medicine 46: 1122-6.
50. Higashi Y, Suzuki S, Sakaguchi T, Nakamura T, Baba S, et al. (2007) Loss of Claudin-1 Expression Correlates with Malignancy of Hepatocellular Carcinoma. Journal of Surgical Research 139: 68-76. (Pubitemid 46482569)
51. Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, et al. (2008) Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. World Journal of Gastroenterology 14: 5665-73.
52. Jiang XM, Zhang JB, Xiong J, Huang XX, Ren ZG (2012) Altered Distribution and Expression Pattern of E-cadherin in Hepatocellular Carcinomas: Correlations with Prognosis and Clinical Features. Asian Pacific Journal of Cancer Prevention 13: 6455-61.
53. Zhang CH, Xu GL, Jia WD, Li JS, Ma JL, et al. (2012) Activation of STAT3 Signal Pathway Correlates with Twist and E-Cadherin Expression in Hepatocellular Carcinoma and Their Clinical Significance. Journal of Surgical Research 174: 120-9.
54. Arias AM (2001) Epithelial mesenchymal interactions in cancer and development. Cell 105: 425-31.
55. Xu XL, Ling ZQ, Chen SZ, Li B, Ji WH, et al. (2014) The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis. Diseases of the Esophagus 27: 79-86.